Clinic
Transamerica Medical Group INC.
Transamerica Medical Group INC. was paid $1.52M by Medicaid between Mar 2018 and Sep 2024, across 44 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.
33Billing provider infoTRANSAMERICA MEDICAL GROUP INC.
TULARE, CA 93274
TULARE, CA 93274
33aNPI1053819177assigned 01/23/2018
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.52M
24GClaims96,995
24DCodes billed44
24AFirst – last monthMar 2018 – Sep 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in California
Rank by total paid#65 of 284
Median peer was paid$147K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,701 | $92K | |
| 2019 | 19,262 | $185K | |
| 2020 | 16,117 | $237K | |
| 2021 | 13,311 | $208K | |
| 2022 | 11,256 | $238K | |
| 2023 | 15,899 | $294K | |
| 2024incomplete | 13,449 | $262K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 18,846 | 15,480 | $377K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15% | 9,186 | 8,816 | $228K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 10,918 | 9,905 | $196K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 6,217 | 6,168 | $194K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.6% | 5,611 | 5,006 | $145K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 6.8% | 11,552 | 8,641 | $102K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.2% | 897 | 884 | $94K |
| 99051 | 3.3% | 8,789 | 7,743 | $50K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 7,336 | 5,231 | $34K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.1% | 3,381 | 2,237 | $17K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 911 | 813 | $17K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 485 | 479 | $12K |
32 more codes
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,626 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,227 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,875 | $8K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,298 | $6K |
| 81003 | <1% | 2,264 | $5K | |
| 99001 | <1% | 922 | $4K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 110 | $2K |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 80 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 175 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 91 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 165 | $897.33 |
| A9150 | Non-prescription drugs | <1% | 418 | $724.20 |
| 73610 | <1% | 58 | $686.11 | |
| 99000 | <1% | 731 | $666.56 | |
| 87807 | <1% | 134 | $565.69 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 52 | $468.78 |
| 73630 | <1% | 31 | $449.78 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 100 | $447.28 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 76 | $242.98 |
| 29540 | <1% | 23 | $223.49 | |
| 73130 | <1% | 12 | $170.46 | |
| 93000 | <1% | 12 | $155.53 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 201 | $87.98 |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 18 | $85.00 |
| 82962 | <1% | 15 | $85.00 | |
| 81025 | <1% | 29 | $52.88 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 26 | $46.59 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 16 | $31.50 |
| 99173 | <1% | 12 | $24.18 | |
| 73562 | <1% | 16 | $23.38 | |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | <1% | 14 | $3.00 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKANG, YADWINDER (OWNER)
| Provider | Location | Paid |
|---|---|---|
| San Joaquin Valley Health Group INC | Bakersfield, CA | $6.49M |
| San Joaquin Valley Health Group INC | Bakersfield, CA | $551K |
| Transamerica Medical Group INC. | Delano, CA | $404K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.